← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2010Last known activity
Jan 18, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT03192462CollaboratorPhase 1/Phase 2Jan 18, 2018
- NCT01437280CollaboratorPhase 1Sep 15, 2011
- NCT01068171CollaboratorN/AMay 31, 2010
- NCT01068171Overall official - principal investigatorN/AMay 31, 2010
- NCT01068171OfficialN/AMay 31, 2010
Details
- Last known activity
- Jan 18, 2018